Salt of salicylic acid for use in treating early stage prostate cancer
A salt of salicylic acid for use as the sole therapeutic entity for treating early stage prostate cancer in a subpopulation of patients who have not previously been treated with either chemotherapy or radiotherapy is disclosed. The salt of salicylic acid may be sodium salicylate. Pharmaceutical prep...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | A salt of salicylic acid for use as the sole therapeutic entity for treating early stage prostate cancer in a subpopulation of patients who have not previously been treated with either chemotherapy or radiotherapy is disclosed. The salt of salicylic acid may be sodium salicylate. Pharmaceutical preparations comprising, and methods of treatment using, the aforementioned salicylic acid salts are also claimed. Alternatively claimed is sodium salicylate itself, without the limitations of it being the sole therapeutic entity for treating early stage prostate cancer. |
|---|